Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection

Table 2

Infection characteristics.

Variable presented as #(%) or median (IQR)	Ceftriaxone (n = 20)	SOCT alone (n = 23)	value
Infection acquisition
Community	11 (55)	10 (43.5)	0.451
Healthcare	5 (25)	9 (39.1)	0.324
Nosocomial	4 (20)	4 (17.4)	1.000
Infection source
Bone/joint	4 (20)	7 (30.4)	0.434
Central line	3 (15)	6 (26.1)	0.467
Central nervous system	1 (5)	0 (0)	0.465
Infective endocarditis (native valve)	0 (0)	1 (4.3)	1.000
Respiratory tract	0 (0)	3 (13)	0.236
Skin/soft tissue/wound	3 (15)	4 (17.4)	1.000
Surgical site	2 (10)	0 (0)	0.210
Unknown	3 (15)	1 (4.3)	0.323
Source control
Controlled	15 (75)	18 (78.3)	1.000
Not controlled	3 (15)	3 (13)	1.000
Unknown	2 (10)	2 (8.7)	1.000
Time to bloodstream clearance, days	5 [3–6]	4 [4–6]	0.892
Infectious diseases consult	19 (95)	18 (78.3)	0.192